Treasurer Of The State Of North Carolina Amgen Inc Transaction History

Treasurer Of The State Of North Carolina

$25 Billion
Q3 2024

A detailed history of Treasurer Of The State Of North Carolina transactions in Amgen Inc stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 259,841 shares of AMGN stock, worth $76.9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

259,841

Previous 261,774 0.74%

Holding current value

$76.9 Million

Previous $81.8 Million 2.36%

% of portfolio

0.33%

Previous 0.35%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $598,031 - $652,155	-1,933 Reduced 0.74%	259,841 $83.7 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $174,991 - $212,660	-666 Reduced 0.25%	261,774 $81.8 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $956,101 - $1.15 Million	3,556 Added 1.37%	262,440 $74.6 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $536,458 - $605,189	2,098 Added 0.82%	258,884 $74.6 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $697,056 - $865,414	3,188 Added 1.26%	256,786 $69 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $374,329 - $442,637	-1,747 Reduced 0.68%	253,598 $56.3 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $915,578 - $1.12 Million	4,055 Added 1.61%	255,345 $61.7 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $1.76 Million - $2.23 Million	7,663 Added 3.15%	251,290 $66 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $877,638 - $989,816	3,910 Added 1.63%	243,627 $54.9 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $1.46 Million - $1.63 Million	-6,347 Reduced 2.58%	239,717 $58.3 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $697,278 - $771,372	-3,180 Reduced 1.28%	246,064 $59.5 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $198,880 - $227,600	1,000 Added 0.4%	249,244 $56.1 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $479,730 - $562,062	-2,260 Reduced 0.9%	248,244 $52.8 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.16 Million - $1.29 Million	-4,980 Reduced 1.95%	250,504 $61.1 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $186,404 - $217,224	840 Added 0.33%	255,484 $63.6 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $311,587 - $371,044	-1,440 Reduced 0.56%	254,644 $58.5 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $434,102 - $482,757	1,850 Added 0.73%	256,084 $65.1 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $6.76 Million - $8.3 Million	-34,190 Reduced 11.85%	254,234 $60 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $2.93 Million - $3.88 Million	16,060 Added 5.9%	288,424 $58.5 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $836,308 - $1.07 Million	4,420 Added 1.65%	272,364 $65.7 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $19.8 Million - $23.8 Million	-113,870 Reduced 29.82%	267,944 $51.9 Million
Q2 2019 Aug 23, 2019	SELL	$166.7 - $195.41 $2.03 Million - $2.38 Million	-12,160 Reduced 3.09%	381,814 $70.4 Million
Q1 2019 Aug 07, 2019	BUY	$180.87 - $203.88 $30,747 - $34,659	170 Added 0.04%	393,974 $74.8 Million
Q4 2018 Aug 07, 2019	SELL	$178.4 - $208.25 $151,283 - $176,596	-848 Reduced 0.21%	393,804 $76.7 Million
Q3 2018 Aug 07, 2019	BUY	$185.29 - $208.89 $22.6 Million - $25.5 Million	121,925 Added 44.71%	394,652 $81.8 Million
Q2 2018 Aug 07, 2019	BUY	$166.05 - $186.51 $26.7 Million - $30 Million	160,834 Added 143.74%	272,727 $50.3 Million
Q1 2018 Jul 24, 2019	BUY	$169.43 - $198.0 $18.6 Million - $21.7 Million	109,793 Added 5228.24%	111,893 $19.1 Million
Q4 2017 May 06, 2019	BUY	$168.79 - $188.59 $354,459 - $396,039	2,100	2,100 $365,000

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.

Account

Treasurer Of The State Of North Carolina Amgen Inc Transaction History